X-Ray Powder Diffraction Technology Developed for Molecule Identification
|
By LabMedica International staff writers Posted on 05 Aug 2014 |

Image: A new method makes it possible to establish very rapidly what substances—proteins and others—a product in powder form contains. For example, a quick analysis of a washing powder developed for the Danish market revealed a high level of zeolite material, which is used to bind limestone from the hard water that is so prevalent in Denmark, while a sample from Morocco contained none of this material. Analysis of another washing powder revealed that “active oxygen is simply the compound sodium percarbonate, i.e., bonded hydrogen peroxide (Photo courtesy of Iben Julie Schmidt).
A Danish researcher has developed a technique that uses X-rays for the rapid identification of substances present in an indeterminate powder. The new technique has the capacity to recognize sophisticated biologic molecules such as proteins. The method therefore has enormous potential in food production and the pharmaceutical industry, where it opens up, for example, new opportunities for the quality assurance (QA) of protein-based drugs. The technique was developed by a Technical University of Denmark (DTU; Kongens Lyngby) researcher.
It is rarely sufficient to read the content information if one needs to know exactly what substances a product contains. One needs to be a very skilled chemist or to have “X-ray vision” to look directly into the molecular structure of the various substances. Christian Grundahl Frankaer, a postdoc in the DTU department of chemical engineering, is almost both, as he has developed technology that allows him to use X-rays to look deep into biologic samples.
The technique is called powder diffraction and involves subjecting a sample to an intense beam of X-rays. When the beam hits the sample, it disseminates in the same manner as light does when reflected by a disco ball. This generates a pattern that reflects the structure of the substance. Each individual substance has its own unique pattern, which makes it easily identifiable when the findings are run through a database.
Powder diffraction is currently used to identify basic substances such as salts, sugars, and minerals, but the theory behind using the same technique to characterize complicated biologic molecules such as proteins is groundbreaking. It is for this reason that the technology has huge possibilities in both food production and the pharmaceutical industry, where more and more attention is being dedicated to protein-based medicines.
“I have tested different types of infant milk formula, protein powders and detergents. By taking a small sample of powder and bombarding it with X-rays, I can determine what substances the powder contains, and in what concentrations, within 10 minutes. In addition, the analysis will typically reveal some information about how the product was made,” noted Dr. Frankaer. The method is therefore perfect for quality assurance of new products on the market.
Dr. Franaer added, “We have now demonstrated that powder diffraction can actually be used on biological substances such as proteins. The results are not as detailed as in single crystal diffraction, which makes it possible to decode the entire structure of the protein, but they do allow us to ‘lift fingerprints’ quickly and easily so that we can identify the protein and its crystal structure. This is valuable knowledge when you are working with the production of proteins.”
The technology has great potential in the framework of optimizing both quality and production processes in all production set-ups that involve solid substances. Applying the new approach will make it possible to check continuously for alterations in—or transformations of—different materials used in the production process. “The advantage of our method is that it allows you to take samples directly from a production line. You then have the results within 15 minutes and can tell precisely what crystalline material is involved. In addition, the X-ray beams we use can easily be generated using standard laboratory equipment,” stated Dr. Frankaer.
The promising findings are just beginning of the project, “What we want to do now is to test how far we can push the method. We have already established that it works on proteins, but will it also work on other complex products? And what happens if we take the samples to the synchrotron in Grenoble [France], where the X-ray beam is a million times more powerful than the one we have in our laboratory?” queried Dr. Frankaer.
Related Links:
Technical University of Denmark
It is rarely sufficient to read the content information if one needs to know exactly what substances a product contains. One needs to be a very skilled chemist or to have “X-ray vision” to look directly into the molecular structure of the various substances. Christian Grundahl Frankaer, a postdoc in the DTU department of chemical engineering, is almost both, as he has developed technology that allows him to use X-rays to look deep into biologic samples.
The technique is called powder diffraction and involves subjecting a sample to an intense beam of X-rays. When the beam hits the sample, it disseminates in the same manner as light does when reflected by a disco ball. This generates a pattern that reflects the structure of the substance. Each individual substance has its own unique pattern, which makes it easily identifiable when the findings are run through a database.
Powder diffraction is currently used to identify basic substances such as salts, sugars, and minerals, but the theory behind using the same technique to characterize complicated biologic molecules such as proteins is groundbreaking. It is for this reason that the technology has huge possibilities in both food production and the pharmaceutical industry, where more and more attention is being dedicated to protein-based medicines.
“I have tested different types of infant milk formula, protein powders and detergents. By taking a small sample of powder and bombarding it with X-rays, I can determine what substances the powder contains, and in what concentrations, within 10 minutes. In addition, the analysis will typically reveal some information about how the product was made,” noted Dr. Frankaer. The method is therefore perfect for quality assurance of new products on the market.
Dr. Franaer added, “We have now demonstrated that powder diffraction can actually be used on biological substances such as proteins. The results are not as detailed as in single crystal diffraction, which makes it possible to decode the entire structure of the protein, but they do allow us to ‘lift fingerprints’ quickly and easily so that we can identify the protein and its crystal structure. This is valuable knowledge when you are working with the production of proteins.”
The technology has great potential in the framework of optimizing both quality and production processes in all production set-ups that involve solid substances. Applying the new approach will make it possible to check continuously for alterations in—or transformations of—different materials used in the production process. “The advantage of our method is that it allows you to take samples directly from a production line. You then have the results within 15 minutes and can tell precisely what crystalline material is involved. In addition, the X-ray beams we use can easily be generated using standard laboratory equipment,” stated Dr. Frankaer.
The promising findings are just beginning of the project, “What we want to do now is to test how far we can push the method. We have already established that it works on proteins, but will it also work on other complex products? And what happens if we take the samples to the synchrotron in Grenoble [France], where the X-ray beam is a million times more powerful than the one we have in our laboratory?” queried Dr. Frankaer.
Related Links:
Technical University of Denmark
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







